These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

756 related items for PubMed ID: 12688292

  • 1. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
    Berger JM.
    Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
    [No Abstract] [Full Text] [Related]

  • 2. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E.
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract] [Full Text] [Related]

  • 3. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
    Joni J.
    Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
    [No Abstract] [Full Text] [Related]

  • 4. Essential AIDS medications in India.
    Thomas J.
    Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
    [No Abstract] [Full Text] [Related]

  • 5. Balancing pills and patents: intellectual property and the HIV/AIDS crisis.
    Nderitu T.
    E Law; 2001 Sep; 8(3):E5. PubMed ID: 16903022
    [No Abstract] [Full Text] [Related]

  • 6. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
    Ghosh S.
    Fla J Int Law; 2002 Sep; 14(2):217-60. PubMed ID: 16526138
    [No Abstract] [Full Text] [Related]

  • 7. Amendments to the Canadian Patent Act to address drug access: is help on the way?
    Penner MD, Narayanan P.
    Food Drug Law J; 2005 Sep; 60(3):459-70. PubMed ID: 16304751
    [No Abstract] [Full Text] [Related]

  • 8. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
    Curti AM.
    Am J Law Med; 2001 Sep; 27(4):469-85. PubMed ID: 11837145
    [No Abstract] [Full Text] [Related]

  • 9. Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime.
    Halliburton M.
    Glob Public Health; 2009 Sep; 4(6):515-27. PubMed ID: 19548158
    [Abstract] [Full Text] [Related]

  • 10. Access to essential drugs, human rights and global justice.
    Shalev C.
    Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Debate on essential medicines heats up.
    Kapp C.
    Lancet Infect Dis; 2001 Nov; 1(4):215. PubMed ID: 11871503
    [No Abstract] [Full Text] [Related]

  • 14. TRIPS: generic irony.
    Howarth GR.
    Br J Gen Pract; 2002 Jan; 52(474):57. PubMed ID: 11791819
    [No Abstract] [Full Text] [Related]

  • 15. In the high court of South Africa, case no. 4138/98: the global politics of access to low-cost AIDS drugs in poor countries.
    Barnard D.
    Kennedy Inst Ethics J; 2002 Jun; 12(2):159-74. PubMed ID: 12476916
    [Abstract] [Full Text] [Related]

  • 16. Medicines for all, not just the rich.
    Davey S.
    Bull World Health Organ; 2001 Jun; 79(4):377-8. PubMed ID: 11357220
    [No Abstract] [Full Text] [Related]

  • 17. Taking TRIPS to India--Novartis, patent law, and access to medicines.
    Mueller JM.
    N Engl J Med; 2007 Feb 08; 356(6):541-3. PubMed ID: 17287473
    [No Abstract] [Full Text] [Related]

  • 18. Access to essential drugs.
    Dev World Bioeth; 2001 Nov 08; 1(2):89-92. PubMed ID: 12870517
    [No Abstract] [Full Text] [Related]

  • 19. Access to HIV drugs: are we changing the two world paradigm?
    Lazzarini Z.
    Conn J Int Law; 2002 Nov 08; 17(2):281-96. PubMed ID: 12688297
    [No Abstract] [Full Text] [Related]

  • 20. New frontier of AIDS activism: international trade rules and global access to medicines. Interview by John S. James.
    Sawyer E.
    AIDS Treat News; 1999 Apr 16; (No 317):1, 5-8. PubMed ID: 11366992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.